SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Jul 22, 2016
Insider Transaction Report
Form 4
Schneebaum Marc R
SVP and CFO
Transactions
- Award
Common Stock
2016-07-22+25,714→ 27,856 total - Tax Payment
Common Stock
2016-07-22$9.48/sh−8,548$81,035→ 19,308 total
Footnotes (3)
- [F1]Represents the vesting and settlement of restricted stock units ("RSUs") upon the completion of the Issuer's merger transaction with Madrigal Pharmaceuticals, Inc. on July 22, 2016.
- [F2]Reflects a 1-for-35 reverse stock split that was effected by the Issuer on July 22, 2016.
- [F3]Shares withheld by the Registrant to satisfy minimum statutory withholding requirements upon vesting of RSUs. Withheld shares were not sold.